US 9980976
Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
granted A61KA61K31/407A61K31/4164
Quick answer
US patent 9980976 (Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists) held by Northwestern University expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/407, A61K31/4164, A61K31/429, A61K31/436